P40 expression in small cell lung cancer: The presence of p40-positive cells does not always indicate squamous...

Small cell lung cancer (SCLC) is normally diagnosed with hematoxylin and eosin stains, although some cases require immunohistochemistry (IHC). P40 is highly sensitive and specific for squamous cell carcinoma and is thus considered the best marker for this cancer. However, the status of p40 expression in SCLC is not well known. The aim of this study was to analyze p40 expression in resected SCLC using IHC.

Forty-four surgically resected SCLC cases were enrolled. Clinical data were obtained from the patients' medical records. Pathologists blinded to the patients' clinical data reviewed the SCLC slides. IHC was performed on a representative slide of each case.

Although p40 was not diffusely expressed in any of the SCLC cases, p40-positive cells were observed in the tumors in 15 cases (34.1%). Ten of these exhibited p40 in < 1% of tumor cells. In the remaining five cases, 1-5% of tumor cells expressed p40, and in three of these, the cells expressing p40 also expressed TTF-1 and neuroendocrine markers. There was no statistically significant relationship between p40 positivity and any other clinicopathological characteristics.

Some resected SCLCs express p40 focally. This result suggests that the presence of positive p40 cells does not exclude a diagnosis of SCLC. Thus, small biopsy or cytology specimens with p40-positive cells must be diagnosed carefully.